These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 23165455)
61. Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression. Fernandes BS; Hodge JM; Pasco JA; Berk M; Williams LJ Drugs Aging; 2016 Jan; 33(1):21-5. PubMed ID: 26547857 [TBL] [Abstract][Full Text] [Related]
62. Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome. Bruyère O; Reginster JY Endocrine; 2015 Feb; 48(1):65-8. PubMed ID: 25091520 [TBL] [Abstract][Full Text] [Related]
63. Medication use before and after hip fracture: a population-based cohort and case-control study. Rossini M; Viapiana O; Adami S; Idolazzi L; Buda S; Veronesi C; Degli Esposti L; Gatti D Drugs Aging; 2014 Jul; 31(7):547-53. PubMed ID: 24825617 [TBL] [Abstract][Full Text] [Related]
64. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies. Wu Q; Bencaz AF; Hentz JG; Crowell MD Osteoporos Int; 2012 Jan; 23(1):365-75. PubMed ID: 21904950 [TBL] [Abstract][Full Text] [Related]
65. Association between use of benzodiazepines and risk of fractures: a meta-analysis. Xing D; Ma XL; Ma JX; Wang J; Yang Y; Chen Y Osteoporos Int; 2014 Jan; 25(1):105-20. PubMed ID: 24013517 [TBL] [Abstract][Full Text] [Related]
66. Relationship between use of antidepressants and risk of fractures: a meta-analysis. Rabenda V; Nicolet D; Beaudart C; Bruyère O; Reginster JY Osteoporos Int; 2013 Jan; 24(1):121-37. PubMed ID: 22638709 [TBL] [Abstract][Full Text] [Related]
67. Tricyclic antidepressant use and risk of fractures: a meta-analysis of cohort and case-control studies. Wu Q; Qu W; Crowell MD; Hentz JG; Frey KA J Bone Miner Res; 2013 Apr; 28(4):753-63. PubMed ID: 23165455 [TBL] [Abstract][Full Text] [Related]
68. Tricyclic Antidepressant Use and Risk of Fractures: A Meta-Analysis of Cohort Studies through the Use of Both Frequentist and Bayesian Approaches. Wu Q; Xu Y; Bao Y; Alvarez J; Gonzales ML J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32785030 [TBL] [Abstract][Full Text] [Related]
69. Depression, fracture risk, and bone loss: a meta-analysis of cohort studies. Wu Q; Liu J; Gallegos-Orozco JF; Hentz JG Osteoporos Int; 2010 Oct; 21(10):1627-35. PubMed ID: 20204602 [TBL] [Abstract][Full Text] [Related]
70. Alendronate for fracture prevention in postmenopause. Holder KK; Kerley SS Am Fam Physician; 2008 Sep; 78(5):579-81. PubMed ID: 18788232 [TBL] [Abstract][Full Text] [Related]
71. Association between use of antiepileptic drugs and fracture risk: a systematic review and meta-analysis. Shen C; Chen F; Zhang Y; Guo Y; Ding M Bone; 2014 Jul; 64():246-53. PubMed ID: 24780876 [TBL] [Abstract][Full Text] [Related]
72. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Cranney A; Wells G; Willan A; Griffith L; Zytaruk N; Robinson V; Black D; Adachi J; Shea B; Tugwell P; Guyatt G; Endocr Rev; 2002 Aug; 23(4):508-16. PubMed ID: 12202465 [TBL] [Abstract][Full Text] [Related]